@FiercePharma: Bond market pants for Pfizer vet unit's debut offering: Zoetis sets up $3.65B in debt amid final prep for IPO. More | Follow @FiercePharma
@AlisonBFierce: FierceVaccines brings you the major FDA vaccine approvals from 2012. Special Report | Follow @AlisonBFierce
> Bayer was cleared of alleged "outrageous" breaches of the U.K. pharma industry's marketing code after officials determined that the suspect ad wasn't misleading. Report
> Neighbors to Novartis' ($NVS) site in West Sussex, England, have complained that the company has not discussed its plans to demolish some buildings, possibly to open land for sale and development. Report
> Japan's Teijin Pharma is preparing to launch Ipsen's Somatuline injection, a treatment for acromegaly and pituitary gigantism, in its home country. Report
> Bosnia's top generics maker, Bosnalijek, predicts a 15% increase in profits for 2013, on top of an 11% increase last year. Report
> The liver cancer market is expected to approach $650 million by 2018, with Bayer's Nexavar continuing to dominate the category, GBI Research found. Report
> The Institute of Medicine concluded that the traditional schedule of childhood vaccines doesn't cause health problems in children as feared. Report (sub. req.)
> A new U.S. drugmaker, Vestiq Pharmaceuticals, has launched with two marketed products bought in from other companies. Report
Biotech News
@FierceBiotech: Popular yesterday: Buzz: $AZN reorg inspires fresh rumors of $SHPG bid. Report | Follow @FierceBiotech
@JohnCFierce: Columnist gushes over Inovio's Kim, a tireless promoter whose stock is trading at .67 and whose flu vax is in PhI. Column | Follow @JohnCFierce
@RyanMFierce: $EXEL's plethora of partnerships bearing fruit as Genentech moves melanoma drug from EXEL into PhIII. More | Follow @RyanMFierce
> FDA green-lights a flu vaccine made with new technology. Story
> Genentech launches PhIII for melanoma combo with GSK in hot pursuit. Article
> AstraZeneca shakeup pushes research chief to top of restructured MedImmune. News
@FierceMedDev: FDA plans to clamp down on all-metal hips. Article | Follow @FierceMedDev
@DamianFierce: Big M&A morning: Stryker's ($SYK) spending $764 million on Chinese orthopedics company Trauson. Release | Follow @DamianFierce
> Stryker to buy Chinese orthopedics biz for $764M. Story
> InfraScan gains FDA backing for next-gen brain hematoma detector. Item
> Analysts: St. Jude at risk for Durata recall. Report
Vaccines News
> IOM confirms safety of childhood vaccine schedule. Report
> CDC: Flu hits epidemic level in U.S. Item
> Protein Sciences nabs Flublok approval. News
> Vaccine stakes upped as dengue dubbed fastest-spreading tropical disease. Article
> Flu vaccine, Tamiflu shortage as influenza sweeps U.S. Story
Pharma Manufacturing News
@EricPFierce: Amgen to build $200 million monoclonal antibody plant in Singapore. Novartis building there too. More | Follow @EricPFierce
> Wisconsin report adds to drug take-back funding debate. Item
> China ups bounty for tips on counterfeiters to $48,500. Report
> Japan's Mitsui ups stake in India API maker Arch. Story
> FDA spells out user fees for generic drugs. Article
> J&J consent decree cost felt at the pharmacy. More
And Finally... The flu vaccine is not linked to fetal death, a new study found. Report